Pharmacopeia Earns Milestone Payment From Wyeth
29 juil. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 29, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that it has received...
Pharmacopeia Advances Therapeutic Program With GlaxoSmithKline
24 juil. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 24, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has...
Pharmacopeia to Present At the BMO Capital Markets 8th Annual Focus On Healthcare Conference
23 juil. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 23, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Joseph A....
Pharmacopeia to Host Second Quarter 2008 Financial Results Webcast and Conference Call
17 juil. 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., July 17, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that the company...
Pharmacopeia and GlaxoSmithKline Collaboration Identifies a New Lead Compound
04 juin 2008 07h30 HE
|
Pharmacopeia, Inc.
PRINCETON, N.J., June 4, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has identified...